Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Covid-19 Pandemic - Additional Information (Details)

v3.22.1
Covid-19 Pandemic - Additional Information (Details)
Dec. 31, 2021
Disclosure of Nature and Extent of Risks Arising from Unusual Risk and Uncertainty By Nature [Abstract]  
Percentage of currently marketed vaccine programs supplied with glass vials and syringes 90.00%